Australia markets open in 1 hour 20 minutes

Vistagen Therapeutics, Inc. (VTGN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.7400-0.0900 (-1.86%)
At close: 04:00PM EDT
4.7000 -0.04 (-0.84%)
After hours: 06:10PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts4244
Avg. Estimate-0.36-0.37-1.6-1.96
Low estimate-0.46-0.38-1.74-2.07
High estimate-0.27-0.36-1.46-1.82
Year ago EPS-1.5-1.75-8.51-1.6
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts4244
Avg. Estimate200k410k1.06M200k
Low estimateN/A400k870kN/A
High estimate410k410k1.28M410k
Year ago sales176kN/AN/A1.06M
Sales growth (year/est)13.60%N/AN/A-81.10%
Earnings history30/12/202230/03/202329/09/202330/12/2023
Est. EPS-2.1-1.5-0.68-0.3
Actual EPS-1.5-1.75-0.66-0.22
Difference0.6-0.250.020.08
Surprise %28.60%-16.70%2.90%26.70%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.36-0.37-1.6-1.96
7 days ago-0.36-0.37-1.6-1.96
30 days ago-0.36-0.37-1.6-1.96
60 days ago-0.36-0.37-1.6-1.96
90 days ago-0.42-0.61-1.84-2.17
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesVTGNIndustrySector(s)S&P 500
Current qtr.76.00%N/AN/AN/A
Next qtr.78.90%N/AN/AN/A
Current year81.20%N/AN/AN/A
Next year-22.50%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A